Institute of NeuroImmune Pharmacology Organization
Overview
webpage
Affiliation
organization within
Research
administers grant
- A CRISP(e)R way to silence HIV
- A LncRNA in Pulmonary Mucosal Immunity and HIV-Associated Comorbidities
- Aberrant Micro-managing of the Airway Epithelial Transcriptome in HIV-associated COPD
- Cell-based Platform for Gene Delivery to the Brain
- Cocaine in the Neuropathogenesis of HIV infection: Role of HDAC-2
- Development of Biotherapeutic Nanogels for Alzheimers Disease Treatment
- Development of Brain Targeted and Biodegradable Polymeric Nano-Formulations for Delivery of Antiretroviral Drugs and Neuroprotectants
- Development of circulating exosomes as a theranostic of neurodisease progression in aviremic HIV+ participants and virological failure
- Development of nanoscale approaches for Zika virus pathogenesis and therapeutics
- Extracellular vesicles for delivery of therapeutic enzyme to treat lysosomal storage disorders.
- Function of astrocytes autophagy in brain homeostasis and opioid-induced maladaptive behavior and addiction, in the context of HIV
- Identify biomarkers of HIV treatment to develop nanogel-based anti-HIV regimen
- Imaging of HIV-infected cells within the brain using nano particle-based photo-acoustic agents.
- Impact of -opioid receptor (MOR) splice variant interactions with the chemokine receptor CCR
- Improving Airway Health in HIV Associated Lung Co-Morbidities
- Intranasal Nanodelivery of Oxytocin to Treat Morphine Addiction in HIV Patients by Gene Editing
- Intranasal-CNS Delivery of ß-NAP Using Novel Simultaneous Spray Technology to Reverse Opiate & HIV-1 Induced Neurodegeneration
- Low Energy External Magnetic Stimulation of Nanoparticles to Disintegrate Amyloid Beta Plaques in Alzheimer's Disease
- Lung comorbidities in HIV patients
- Mechanisms of defective mitophagy and cellular senescence in HIV associated COPD
- Nano-delivery of methanandamide across BBB to block cannabinoid induced effects in HIV-1 infection
- Nanotechnology Based Gene Editing to Eradicate HIV Brain Reservoir in Drug Abusers
- Nanotechnology based eradication of Ovarian Cancer
- Neurocognitive implications of cannabidiol (CBD) while aging with HIV
- Novel approaches to Eliminating HIV Latency
- Novel long noncoding RNAs in the airway mucous response
- Novel long noncoding RNAs in the airway mucous response
- Novel role of TFEB in ADAM10 potentiation and proliferation of neural precursor cells relevant to Alzheimer's disease
- Pathophysiological Mechanisms and Therapeutics for Chronic Lung Inflammation in Smokers and in COPD
- Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
- Preclinical model efficacy testing of a Photoelectrochemical Oxidative Filter-Based Air Purification Unit in Mitigating the Hyperreactive Respiratory Responses to Inhaled Allergens
- Resetting the Clock in HIV associated COPD
- Restoring mucociliary clearance apparatus to mitigate lung inflammation in the context of HIV and cigarette smoke
- Role of exosome extracellular vesicles in opiate abuse and HIV neuropathogenesis
- Sustained Release of Nano-Medicine up to one month for the Treatment of HIV-1 infection
- Synthetic cannabinoids and their effects on extracellular histone release and inflammation: using single cell imaging flow cytometry as a novel epigenetic tool
- TFEB Activator for Alzheimer's Disease Therapy
- Targeting Chronic Mucous Hypersecretion Using a Small Molecule Inhibitor
- Targeting Hyperplastic Airway Cells Using a Small Molecule Inhibitor
- Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid.
- The potential benefits of autophagy activator TFEB in opioid use disorder in mice
- Therapeutic Effect of Withaferin A and miR-Chimera on Alzheimer's Disease Cell Culture Models
- Therapeutic role of Withaferin A and CRID3 in the prevention of AD. A Novel Nanotechnology Approach
- Tracheobronchial mucociliary dysfunction in HIV patients
- Zika Virus Research